Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)

Clinical trial NCT02194634 · UNKNOWN

Trial details

NCT number: NCT02194634
Sponsor: Chengdu Kanghong Biotech Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2014-07-01
Primary completion: 2016-12-01
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.